Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 204 of 1,261

  1. US 11607435

    Probiotics Bifidobacteria strains

    PERFECT (CHINA) CO., LTD. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  2. US 11607450

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics, Inc. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  3. US 11607427

    Method for chemoselection

    The Regents of the University of California · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  4. US 11607456

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  5. US 11607462

    Systems and methods for minimally-invasive assessment of toxicity-induced tissue injury

    Northwestern University · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  6. US 11607448

    Whole avian-origin reverse genetic system and its use in producing H7N9 subtype avian influenza vaccine

    SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  7. US 11608354

    Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease

    Theravance Biopharma R&D IP, LLC · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  8. US 11607412

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    TENAX THERAPEUTICS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  9. US 11607387

    Efficient aqueous encapsulation and controlled release of bioactive agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  10. US 11607426

    Method of targeting oncolytic viruses to tumors

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  11. US 11607407

    Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use

    Relmada Therapeutics, Inc. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  12. US 11608454

    High performance adhesives; methods of making; and use

    South China University of Technology · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  13. US 11607408

    Method of treatment of schizophrenia

    VANDA PHARMACEUTICALS INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  14. US 11603406

    Antibodies binding to VISTA at acidic pH

    Five Prime Therapeutics, Inc. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  15. US 11603364

    Acyl hydrazone derivative compounds for treating disease

    Alterity Therapeutics Limited · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  16. US 11602568

    Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them

    The Regents of the University of California · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  17. US 11602567

    Methods for modulating RNA splicing

    PTC THERAPEUTICS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  18. US 11602515

    Pharmaceutical compositions comprising dimethyl fumarate

    Almirall, S.A. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  19. US 11603412

    Antibodies against CDCP1 for the treatment and detection of cancer

    The Regents of the University of California · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  20. US 11603413

    Anti-TMPRSS2 antibodies and antigen-binding fragments

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  21. US 11603519

    T-cell receptor

    Takeda Pharmaceutical Company Limited · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  22. US 11603407

    Stable antibody formulation

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  23. US 11603376

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  24. US 11602559

    HIV-1 Env fusion peptide immunogens and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.